<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font24 { font-size : 24; } .font26 { font-size : 26; } .font28 { font-size : 28; } .font30 { font-size : 30; } .font31 { font-size : 31; }</style>
 <body>
  <p>
   <span class="font31">men </span>
   <span class="font31">testosterone </span>
   <span class="font30">male </span>
   <span class="font28">contraceptive </span>
   <span class="font26">hormonal </span>
   <span class="font24">efficacy </span>
   <span class="font21">suppression </span>
   <span class="font20">sperm </span>
   <span class="font17">{border-style </span>
   <span class="font17">Endocrinol </span>
   <span class="font17"> mg </span>
   <span class="font17">px;} </span>
   <span class="font16">#ffffff;} </span>
   <span class="font16">Metab </span>
   <span class="font16">effects </span>
   <span class="font16">studies </span>
   <span class="font16">azoospermia </span>
   <span class="font15">Clin </span>
   <span class="font15">dose </span>
   <span class="font15">phase </span>
   <span class="font15">plus </span>
   <span class="font15">rate </span>
   <span class="font15">contraception </span>
   <span class="font15">oral </span>
   <span class="font15">total </span>
   <span class="font15">recovery </span>
   <span class="font15">study </span>
   <span class="font14">-month </span>
   <span class="font14">method </span>
   <span class="font14">reported </span>
   <span class="font14">effective </span>
   <span class="font14">injectable </span>
   <span class="font14">trial </span>
   <span class="font14">undecanoate </span>
   <span class="font13">contraception. </span>
   <span class="font13">failure </span>
   <span class="font13">combination </span>
   <span class="font13">combined </span>
   <span class="font13">demonstrated </span>
   <span class="font13">regimen </span>
   <span class="font13">treatment </span>
   <span class="font13">Testosterone </span>
   <span class="font13">clinical </span>
   <span class="font13">contraception: </span>
   <span class="font13">different </span>
   <span class="font13">injection </span>
   <span class="font13">injections </span>
   <span class="font13">pregnancies </span>
   <span class="font13">px; </span>
   <span class="font13">spermatogenesis </span>
   <span class="font13">{font-family </span>
   <span class="font12">GnRH </span>
   <span class="font12">Health </span>
   <span class="font12">Meriggiola </span>
   <span class="font12">NES </span>
   <span class="font12">acne, </span>
   <span class="font12">enanthate </span>
   <span class="font12">font-size </span>
   <span class="font12">healthy </span>
   <span class="font12">phase, </span>
   <span class="font12">phase. </span>
   <span class="font12">pregnancy </span>
   <span class="font12">progestin </span>
   <span class="font12">regimens </span>
   <span class="font12">severe </span>
   <span class="font12">study. </span>
   <span class="font12">subjects </span>
   <span class="font12">time </span>
   <span class="font12">use </span>
   <span class="font12">using </span>
   <span class="font12">Contraceptive </span>
   <span class="font12">Male </span>
   <span class="font12">Swerdloff </span>
   <span class="font12">administered </span>
   <span class="font12">administration </span>
   <span class="font12">androgen </span>
   <span class="font12">antagonists </span>
   <span class="font12">concentration </span>
   <span class="font12">depot </span>
   <span class="font12">development </span>
   <span class="font12">double; </span>
   <span class="font12">hormone </span>
   <span class="font12">included </span>
   <span class="font12">increased </span>
   <span class="font12">large </span>
   <span class="font12">men. </span>
   <span class="font12">mood </span>
   <span class="font12">new </span>
   <span class="font12">normal </span>
   <span class="font12">potential </span>
   <span class="font12">safety </span>
   <span class="font12">study, </span>
   <span class="font12">suppression. </span>
   <span class="font12">transdermal </span>
   <span class="font11">&amp;lt; </span>
   <span class="font11">(.) </span>
   <span class="font11">-week </span>
   <span class="font11">Contraception </span>
   <span class="font11">Hormonal </span>
   <span class="font11">NETE </span>
   <span class="font11">Wang </span>
   <span class="font11">active </span>
   <span class="font11">adverse </span>
   <span class="font11">associated </span>
   <span class="font11">attributed </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">effects. </span>
   <span class="font11">end </span>
   <span class="font11">extent </span>
   <span class="font11">family </span>
   <span class="font11">formulations </span>
   <span class="font11">higher </span>
   <span class="font11">methods. </span>
   <span class="font11">performed </span>
   <span class="font11">rates </span>
   <span class="font11">received </span>
   <span class="font11">research </span>
   <span class="font11">reversible </span>
   <span class="font11">safe </span>
   <span class="font11">solid; </span>
   <span class="font11">studied </span>
   <span class="font11">threshold </span>
   <span class="font11">trials </span>
   <span class="font11">used </span>
   <span class="font11">women </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font11">Androl </span>
   <span class="font11">Asian </span>
   <span class="font11">Chinese </span>
   <span class="font11">Lancet </span>
   <span class="font11">Reprod </span>
   <span class="font11">acceptability </span>
   <span class="font11">achieve </span>
   <span class="font11">androgenic </span>
   <span class="font11">bold </span>
   <span class="font11">compared </span>
   <span class="font11">completed </span>
   <span class="font11">contraceptives </span>
   <span class="font11">count </span>
   <span class="font11">courier; </span>
   <span class="font11">decrease </span>
   <span class="font11">discontinued </span>
   <span class="font11">effective, </span>
   <span class="font11">em; </span>
   <span class="font11">female </span>
   <span class="font11">followed </span>
   <span class="font11">gain, </span>
   <span class="font11">gel </span>
   <span class="font11">induced </span>
   <span class="font11">initial </span>
   <span class="font11">mechanism </span>
   <span class="font11">molecules </span>
   <span class="font11">months </span>
   <span class="font11">norethisterone </span>
   <span class="font11">oligozoospermia </span>
   <span class="font11">oligozoospermic </span>
   <span class="font11">participants </span>
   <span class="font11">period. </span>
   <span class="font11">person-years </span>
   <span class="font11">placebo-controlled </span>
   <span class="font11">possible </span>
   <span class="font11">progress </span>
   <span class="font11">pt;} </span>
   <span class="font11">showed </span>
   <span class="font11">shown </span>
   <span class="font11">single </span>
   <span class="font11">sites, </span>
   <span class="font11">spermatogenesis. </span>
   <span class="font11">tested </span>
   <span class="font11">treated </span>
   <span class="font11">volunteers </span>
   <span class="font11">week </span>
   <span class="font11">weeks </span>
   <span class="font11">weight </span>
   <span class="font11">work </span>
   <span class="font11"> mg/ </span>
   <span class="font11"> million/ml </span>
  </p>
 </body>
</html>
